Cellyan Biotechnology (HKPD)

• Market cap: $9.87M
• 1 day: 2.51%
• 5 days: -4.42%
• 1 month: -1.64%
• 3 months: -34.38%
• 6 months: -49.01%
• Year to date: -47.94%
• 1 year: -63.16%
• 5 years: -85.11%
• 10 years: -85.11%
• Sector: Healthcare
• Industry: Medical Distribution

About: Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.

Employees: 27